Loreto Pharmaceuticals Private Limited
About Loreto Pharmaceuticals Private Limited
Data last updated:
Loreto Pharmaceuticals Private Limited is a private limited company based in Cheranellore, Kerala, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 13 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2013PTC034749. Its GSTIN is 32AACCL5417H1ZT (Kerala).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹14 Lakh. It is led by directors including Sijo Mookilikattu Antony (Managing Director) and Chaithanya Renji Kunjappan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D. I. P. Centre Pallikavala Near Autostand Pallikavala, Cheranellore, Kerala, India – 682034.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.63 Cr, a decline of 50% compared to the previous year. For the same year it recorded a net loss of ₹1.87 Lakh (net margin -1.1%) and EBITDA of ₹51,678 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD. I. P. Centre Pallikavala Near Autostand Pallikavala, Cheranellore, Kerala, India – 682034
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Loreto Pharmaceuticals Private Limited
The main business activity of Loreto Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Loreto Pharmaceuticals Private Limited FY 2025 filings available
Loreto Pharmaceuticals Private Limited reported revenue of ₹1.63 Cr (down 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Loreto Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 50% fall in the latest year. EBITDA rose 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Loreto Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹51,678 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.87 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Loreto Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Loreto Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cardimes Pharmaceuticals Private Limited | ₹1.64 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Mumbai, Maharashtra, India |
| Pharma French Pharmaceuticals India Private Limited | ₹1.64 Cr (FY 2018) | •••• | •••• | -88.0% | •••• | Coimbatore, Tamil Nadu, India |
| Care-Med Pharmaceuticals Private Limited | ₹1.64 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Chennai, Tamil Nadu, India |
| Smith and Kenner Pharmaceuticals Pvt Ltd | ₹1.63 Cr (FY 2024) | •••• | •••• | -53.0% | •••• | Telangana, India |
| Ebm Drugs & Pharmaceuticals Private Limited | ₹1.63 Cr (FY 2021) | •••• | •••• | -34.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Loreto Pharmaceuticals Private Limited this company | ₹1.63 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Cheranellore, Kerala, India |
| Rods N Cones Pharmaceuticals Private Limited | ₹1.63 Cr (FY 2024) | •••• | •••• | 260.0% | •••• | Jaipur, Rajasthan, India |
| Invasion Pharmaceuticals Private Limited | ₹1.62 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Ahmedabad, Gujarat, India |
| Medexcel Pharmaceuticals Private Limited | ₹1.62 Cr (FY 2017) | •••• | •••• | 1257.0% | •••• | Guwahati, Assam, India |
| Samarpan Pharmaceuticals Private Limited | ₹1.61 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Mumbai, Maharashtra, India |
| Novanex Pharmaceuticals Private Limited | ₹1.61 Cr (FY 2025) | •••• | •••• | 191.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Loreto Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals Private Limited is audited by SAJIVE ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAJIVE ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chaithanya Renji Kunjappan | Director | 04 Jul 2018 | 8 Years 3 Months | Current |
| Sijo Mookilikattu Antony Also directs: Corerays Limited Liability Partnership | Managing Director | 13 Aug 2013 | 13 Years 2 Months | Current |
| Priyanka Babu | Director | 13 Aug 2013 | 13 Years 2 Months | Current |
Ownership and Shareholding of Loreto Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Loreto Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2016 | Idbi Bank Limited | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Loreto Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Loreto Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Arun ceased to be Director on 31 Mar 2021.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Loreto Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Loreto Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Loreto Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AACCL5417H1ZT | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Loreto Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Loreto Pharmaceuticals Private Limited
Loreto Pharmaceuticals is an active private limited company based in Cheranellore, Kerala, India. The company works in other wholesale, within the trading industry. It was incorporated on 13 August 2013 (13+ years old) and is registered under CIN U51397KL2013PTC034749.
Loreto Pharmaceuticals reported revenue of ₹1.63 Cr for FY 2025 (down 50% YoY).
Loreto Pharmaceuticals has 3 current directors:
- Sijo Mookilikattu Antony - Managing Director
- Chaithanya Renji Kunjappan - Director
- Priyanka Babu - Director
Loreto Pharmaceuticals reported a net loss of ₹1.87 Lakh (net margin -1.1%) and EBITDA of ₹51,678 (EBITDA margin 0.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Loreto Pharmaceuticals is -21% over three years and -2% over five years. In the latest year (FY 2025) revenue fell 50%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Loreto Pharmaceuticals is 32AACCL5417H1ZT, registered in Kerala.
The CIN (Corporate Identification Number) of Loreto Pharmaceuticals is U51397KL2013PTC034749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Loreto Pharmaceuticals was incorporated on 13 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Loreto Pharmaceuticals by revenue are Cardimes Pharmaceuticals Private Limited, Pharma French Pharmaceuticals India Private Limited, Care-Med Pharmaceuticals Private Limited, Smith and Kenner Pharmaceuticals Pvt Ltd, Ebm Drugs & Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arun ceased to be Director on 31 Mar 2021. Bindu Sivaramapillai ceased to be Director on 31 Mar 2021. Theke Cheekkilote Abhilash Narayan ceased to be Director on 31 Mar 2021. Loreto Pharmaceuticals has 9 board changes on record in total.
The registered office of Loreto Pharmaceuticals is at D. I. P. Centre Pallikavala Near Autostand Pallikavala, Cheranellore, Kerala, India – 682034.